![](/img/cover-not-exists.png)
Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon β-1b in patients with relapsing-remitting multiple sclerosis
Dr. Omar A. Khan, J. Richard HebelVolume:
44
Year:
1998
Language:
english
Pages:
2
DOI:
10.1002/ana.410440123
File:
PDF, 230 KB
english, 1998